Abstract:The schematic presentation depicts the mechanism by which the Semaphorin3A (Sema3A)‐positive small extracellular vesicle (sEV)/neuropilin‐1 (NRP1) axis meditates microvascular rarefaction. The mechanism of impaired angiogenesis involves Sema3A‐positive sEVs competing with vascular endothelial growth factor A for binding to NRP1, to inhibit the adaptive angiogenic response. In addition, communication between microvascular endothelial cells and fibroblasts via Sema3A‐containing sEVs causes myofibroblast activation and promotes the development and progression of cardiac fibrosis. Microvascular endothelial cells (MiVECs) impair angiogenic potential, leading to microvascular rarefaction, which is a characteristic feature of chronic pressure overload‐induced cardiac dysfunction. Semaphorin3A (Sema3A) is a secreted protein upregulated in MiVECs following angiotensin II (Ang II) activation and pressure overload stimuli. However, its role and mechanism in microvascular rarefaction remain elusive. The function and mechanism of action of Sema3A in pressure overload‐induced microvascular rarefaction, is explored, through an Ang II‐induced animal model of pressure overload. RNA sequencing, immunoblotting analysis, enzyme‐linked immunosorbent assay, quantitative reverse transcription polymerase chain reaction (qRT‐PCR), and immunofluorescence staining results indicate that Sema3A is predominantly expressed and significantly upregulated in MiVECs under pressure overload. Immunoelectron microscopy and nano‐flow cytometry analyses indicate small extracellular vesicles (sEVs), with surface‐attached Sema3A, to be a novel tool for efficient release and delivery of Sema3A from the MiVECs to extracellular microenvironment. To investigate pressure overload‐mediated cardiac microvascular rarefaction and cardiac fibrosis in vivo, endothelial‐specific Sema3A knockdown mice are established. Mechanistically, serum response factor (transcription factor) promotes the production of Sema3A; Sema3A‐positive sEVs compete with vascular endothelial growth factor A to bind to neuropilin‐1. Therefore, MiVECs lose their ability to respond to angiogenesis. In conclusion, Sema3A is a key pathogenic mediator that impairs the angiogenic potential of MiVECs, which leads to cardiac microvascular rarefaction in pressure overload‐induced heart disease.

Expression of Semaphorin3E/PlexinD1 in human airway smooth muscle cells of patients with COPD

Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.

Semaphorin 5A Promotes Th17 Differentiation Via PI3K-Akt-mTOR in Systemic Lupus Erythematosus

Eosinophils Promote Pulmonary Matrix Destruction and Emphysema Via Cathepsin L

CD11c+ dendritic cells PlexinD1 deficiency exacerbates airway hyperresponsiveness, IgE and mucus production in a mouse model of allergic asthma

013 Semaphrin4D Drives CD8+ T Cells Skin Trafficking in Oral Lichen Planus Via CXCL9 and CXCL10 Upregulations in Oral Keratinocytes

Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras.

Sphingosylphosphorylcholine Induces Α-Smooth Muscle Actin Expression in Human Lung Fibroblasts and Fibroblast-Mediated Gel Contraction Via S1P2 Receptor and Rho/Rho-kinase Pathway

Extracellular matrix promotes proliferation, migration and adhesion of airway smooth muscle cells in a rat model of chronic obstructive pulmonary disease via upregulation of the PI3K/AKT signaling pathway

Immunosuppressive Regulation of Dendritic Cells and T Cells in Allergic Rhinitis by Semaphorin 3A

Sema3e/Plexin D1 Modulates Immunological Synapse and Migration of Thymocytes by Rap1 Inhibition

Endothelial Semaphorin 7A Promotes Seawater Aspiration-Induced Acute Lung Injury Through Plexin C1 and Β1 Integrin

Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells

Correlation between sestrin2 expression and airway remodeling in COPD

PLXNA2 identified as a candidate gene by genome-wide association analysis for mandibular prognathism in human chondrocytes.

Semaphorin 3a Inhibits Allergic Inflammation By Regulating Immune Responses In A Mouse Model Of Allergic Rhinitis

Semaphorin4A promotes lung cancer by activation of NF-κB pathway mediated by PlexinB1

Reduced Expression of Semaphorin 4D and Plexin-B in Breast Cancer is Associated with Poorer Prognosis and the Potential Linkage with Oestrogen Receptor.

Semaphorin3A Exacerbates Cardiac Microvascular Rarefaction in Pressure Overload‐Induced Heart Disease

Syndecan-1 Amplifies Ovalbumin-Induced Airway Remodeling by Strengthening TGFβ1/Smad3 Action

Epithelial and endothelial cell plasticity in chronic obstructive pulmonary disease (COPD)